2.03
0.05 (2.53%)
| Penutupan Terdahulu | 1.98 |
| Buka | 1.98 |
| Jumlah Dagangan | 339,700 |
| Purata Dagangan (3B) | 784,566 |
| Modal Pasaran | 50,803,952 |
| Harga / Jualan (P/S) | 0.110 |
| Harga / Buku (P/B) | 0.400 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 13 May 2025 - 19 May 2025 |
| Margin Keuntungan | -25.40% |
| Margin Operasi (TTM) | -12.75% |
| EPS Cair (TTM) | -4.61 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -11.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 263.27% |
| Nisbah Semasa (MRQ) | 1.57 |
| Aliran Tunai Operasi (OCF TTM) | -4.76 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 19.30 M |
| Pulangan Atas Aset (ROA TTM) | -4.78% |
| Pulangan Atas Ekuiti (ROE TTM) | -56.93% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Menurun | Menurun |
| Diagnostics & Research (Global) | Menurun | Menurun | |
| Stok | Inotiv, Inc. | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -4.0 |
| Purata | -0.38 |
|
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 11.49% |
| % Dimiliki oleh Institusi | 26.27% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Kpp Advisory Services Llc | 31 Dec 2024 | 275,267 |
| Julat 52 Minggu | ||
| Median | 5.00 (146.31%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Lake Street | 08 May 2025 | 5.00 (146.31%) | Beli | 2.03 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 23 Apr 2025 | Pengumuman | Inotiv, Inc. to Report Fiscal 2025 Second Quarter Financial Results and Host Conference Call on Wednesday, May 7, 2025 |
| 06 Apr 2025 | Pengumuman | Sea Pharmaceuticals Announces Strategic Relationship to Advance Treatments For Patients with CNS Disorders |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |